Avril MF - Search Results

1

IL-2 phase II trial in metastatic melanoma: analysis of clinical and immunological parameters.

Dorval T, Mathiot C, Chosidow O, Revuz J, Avril MF, Guillaume JC, Tursz T, Brandely M, Pouillart P, Fridman WH. Dorval T, et al. Among authors: avril mf. Biotechnol Ther. 1992;3(1-2):63-79. Biotechnol Ther. 1992. PMID: 1305893 Clinical Trial.

2

[Vitiligo-like lesions in melanoma treated with interleukin-2: 4 cases].

Wolkenstein P, Chosidow O, Guillaume JC, Wechsler J, Avril MF, Revuz J. Wolkenstein P, et al. Among authors: avril mf. Ann Dermatol Venereol. 1992;119(11):907-9. Ann Dermatol Venereol. 1992. PMID: 1301719 French. No abstract available.

3

[Phase I trial of a recombinant human interleukin 2. Results in patients with disseminated solid tumors].

Tursz T, Dorval T, Berthaud P, Jouve M, Avril MF, Garcia-Giralt E, Le Chevalier T, Spielmann M, Sevin D, Palangie T, et al. Tursz T, et al. Among authors: avril mf. Presse Med. 1991 Feb 16;20(6):250-4. Presse Med. 1991. PMID: 1826163 French.

4

[Treatment of metastatic melanoma with dacarbazine recombinant interferon alfa 2A combination: results of multicentric study].

Avril MF, Beerblock K, Dreno B, Delaunay M, Bonerandi JJ, Guillaume JC, Souteyrand P, Kalis B, Chevrant-Breton J, Verret J, et al. Avril MF, et al. Bull Cancer. 1990;77(12):1183-91. Bull Cancer. 1990. PMID: 2081278 Clinical Trial. French.

5

A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.

Boue F, Pastran Z, Spielmann M, Le Chevalier T, Subirana R, Sevin D, Paoletti C, Brandely M, Avril MF, Sancho-Garnier H, et al. Boue F, et al. Among authors: avril mf. Cancer Immunol Immunother. 1990;32(1):67-70. doi: 10.1007/BF01741727. Cancer Immunol Immunother. 1990. PMID: 2126985 Free PMC article. Clinical Trial.

6

Cutaneous side effects associated with interleukin 2 administration for metastatic melanoma.

Wolkenstein P, Chosidow O, Wechsler J, Guillaume JC, Lescs MC, Brandely M, Avril MF, Revuz J. Wolkenstein P, et al. Among authors: avril mf. J Am Acad Dermatol. 1993 Jan;28(1):66-70. doi: 10.1016/0190-9622(93)70011-h. J Am Acad Dermatol. 1993. PMID: 8425972 Clinical Trial.

7

Randomized trial of treatment with cisplatin and interleukin-2 either alone or in combination with interferon-alpha-2a in patients with metastatic melanoma: a Federation Nationale des Centres de Lutte Contre le Cancer Multicenter, parallel study.

Dorval T, Négrier S, Chevreau C, Avril MF, Baume D, Cupissol D, Oskam R, de Peuter R, Vinke J, Herrera A, Escudier B. Dorval T, et al. Among authors: avril mf. Cancer. 1999 Mar 1;85(5):1060-6. doi: 10.1002/(sici)1097-0142(19990301)85:5<1060::aid-cncr8>3.0.co;2-2. Cancer. 1999. PMID: 10091789 Clinical Trial.

8

Regression of primary melanoma with metastases.

Avril MF, Charpentier P, Margulis A, Guillaume JC. Avril MF, et al. Cancer. 1992 Mar 15;69(6):1377-81. doi: 10.1002/1097-0142(19920315)69:6<1377::aid-cncr2820690613>3.0.co;2-n. Cancer. 1992. PMID: 1540876 Review.

9

[What is your diagnosis? Hyperpigmentation caused by minocycline].

Bamberger N, Guillaume JC, Avril MF. Bamberger N, et al. Among authors: avril mf. Ann Dermatol Venereol. 1990;117(4):299-300. Ann Dermatol Venereol. 1990. PMID: 1695075 French. No abstract available.

10

Malignant melanoma and granulomatosis.

Robert C, Schoenlaub P, Avril MF, Lok C, Grosshans E, Valeyre D, Bourgeois C, Pinquier L, Dubertret L, Guillaume JC. Robert C, et al. Among authors: avril mf. Br J Dermatol. 1997 Nov;137(5):787-92. Br J Dermatol. 1997. PMID: 9415243

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

393 results

Search Page

Filters